rs3846326
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000901.5(NR3C2):c.1758-28447C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.719 in 152,184 control chromosomes in the GnomAD database, including 40,197 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.72 ( 40197 hom., cov: 33)
Consequence
NR3C2
NM_000901.5 intron
NM_000901.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.16
Publications
2 publications found
Genes affected
NR3C2 (HGNC:7979): (nuclear receptor subfamily 3 group C member 2) This gene encodes the mineralocorticoid receptor, which mediates aldosterone actions on salt and water balance within restricted target cells. The protein functions as a ligand-dependent transcription factor that binds to mineralocorticoid response elements in order to transactivate target genes. Mutations in this gene cause autosomal dominant pseudohypoaldosteronism type I, a disorder characterized by urinary salt wasting. Defects in this gene are also associated with early onset hypertension with severe exacerbation in pregnancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
NR3C2 Gene-Disease associations (from GenCC):
- autosomal dominant pseudohypoaldosteronism type 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- pseudohyperaldosteronism type 2Inheritance: AD, Unknown Classification: LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.813 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.720 AC: 109418AN: 152066Hom.: 40172 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
109418
AN:
152066
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.719 AC: 109493AN: 152184Hom.: 40197 Cov.: 33 AF XY: 0.720 AC XY: 53581AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
109493
AN:
152184
Hom.:
Cov.:
33
AF XY:
AC XY:
53581
AN XY:
74406
show subpopulations
African (AFR)
AF:
AC:
23552
AN:
41500
American (AMR)
AF:
AC:
11668
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
2817
AN:
3472
East Asian (EAS)
AF:
AC:
4313
AN:
5172
South Asian (SAS)
AF:
AC:
3888
AN:
4826
European-Finnish (FIN)
AF:
AC:
7468
AN:
10594
Middle Eastern (MID)
AF:
AC:
249
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53148
AN:
68008
Other (OTH)
AF:
AC:
1561
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1524
3049
4573
6098
7622
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.